Across TCGA pan-cancer cohorts, HSBP1P1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of HSBP1P1’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where HSBP1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types HSBP1P1 is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.
KIRC, COAD, and LUAD are the cancer types where HSBP1P1 tumor–normal differential expression is most reproducible.